• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 57,210.45
    454.45 (+0.80%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,489.95(%)
  • One 97
    1,090.00 1,090.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 765.00(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 205.60(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 208.95(%)
  • Monika Alcobev
    289.95 289.95(%)
  • St Bk of India
    825.00 889.00(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bafna Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 28611.0
  • ISIN : INE878I01022
89.18 0 (0.20%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    88.00

  • Today’s High

    90.50

  • Open

    90.50

  • Perv Close

    89.00

  • 52W Low

    69.00

  • 52W High

    94.99

Key Indicators

  • P/E(TTM)

    33.65

  • Mar.Cap (₹Cr.)

    210.97

  • Div & Yield %

    0.00

  • Book Value(₹)

    35.85

  • Debt-Equity Ratio

    0.20

  • AGM Date

    23-Jul-2025

  • EPS

    2.66

  • P/E Ratio

    33.65

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    210.97

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    23.66

  • BV (₹)

    35.80

  • Sales( ₹ in Cr.)

    145.86

  • NP (in Cr.)

    6.30

  • NP Var(%)

    -14.0

  • Div%

    0.0

  • CPS (₹)

    4.70

  • EPS (₹)

    2.70

  • Traded Value (₹ in Lakhs)

    211.72

  • 52 Week High

    94.99

  • 52 Week Low

    69.00

  • Price BSE

    90.0

  • Price NSE

    89.00

  • Market Capital( in Cr.)

    211.72

  • P/C Ratio

    19.00

  • P/E Ratio

    33.80

  • Price Vs.BV

    2.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 152.47 115.35 85.14 71.22 42.47 43.63
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 152.47 115.35 85.14 71.22 42.47 43.63
Other Income 3.52 3.27 1.70 0.75 0.26 0.39
Stock Adjustments 4.85 2.91 1.77 -2.95 3.24 -0.81
Total Income 160.84 121.53 88.61 69.02 45.97 43.21
EXPENDITURE :            
Raw Materials 91.58 65.98 41.70 33.58 23.22 27.00
Power and Fuel Cost 6.73 5.31 3.93 2.95 2.69 2.50
Employee Cost 19.03 15.87 14.65 11.98 10.25 9.01
Other Manufacturing Expenses 13.83 8.68 7.72 6.72 5.02 4.48
Selling and Administration Expenses 13.98 5.39 6.92 2.67 3.18 3.13
Miscellaneous Expenses 1.06 1.33 2.19 0.07 23.45 9.77
Employee Benefit Expenses 19.03 15.87 14.65 11.98 10.25 9.01
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 146.20 102.55 77.11 57.97 67.80 55.89
Operating Profit 14.63 18.99 11.50 11.04 -21.84 -12.68
Interest 2.29 2.04 0.79 0.74 0.10 2.13
Gross Profit 12.34 16.95 10.71 10.30 -21.94 -14.81
Depreciation 5.00 5.33 5.49 4.48 3.27 3.42
Profit Before Tax 7.34 11.62 5.22 5.82 -25.21 -18.23
Current Tax 0.00 0.28 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 1.50
Reported Net Profit 7.35 11.34 5.22 5.83 -25.20 -19.73
Extraordinary Items 0.07 0.20 -2.16 0.00 -23.33 0.00
Adjusted Net Profit 7.28 11.14 7.38 5.83 -1.87 -19.73
Adjustment below Net Profit 0.04 0.15 -0.02 0.00 0.00 0.00
P & L Balance brought forward -54.48 -65.97 -71.17 -76.99 -51.79 -32.06
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -47.10 -54.48 -65.97 -71.17 -76.99 -51.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.11 4.79 2.21 2.46 -106.54 0.00
Earnings Per Share(Adj)-Unit Curr 3.11 4.79 2.21 2.46 -106.54 0.00
Book Value 34.17 31.05 26.19 24.00 -18.64 8.79
Book Value(Adj)-Unit Curr 34.17 31.05 26.19 24.00 -18.64 8.79

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 1,989 0.01 1,989 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 100,246 0.42 100,246 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 17,742,251 75.00 17,742,251 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,209,803 9.34 2,209,803 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,209,803 9.34 2,209,803 3
2] Non Institution
Bodies Corporate 583,688 2.47 583,188 49
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 189,387 0.80 189,387 72
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 88,063 0.37 88,063 209
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,481,509 6.26 1,481,509 12
Individuals holding nominal share capital up to Rs. 1 lakh 1,266,486 5.35 1,259,946 6,926
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,137 0.01 2,137 1
Sub Total 3,704,281 15.66 3,697,241 7,273
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 23,656,335 100.00 23,649,295 7,283

Company Background

Bafna Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Bafna Pharmaceuticals Ltd
  • BSE Code : 28611.0
  • ISIN : INE878I01022

  • Incorporation Year

    1995

  • Registered Office

    Bafna Towers New No 68
    Old No 299 Thambu Chetty St, Chennai,
    Tamil Nadu-600001

  • Telephone

    91-44-25267517/25270992/4267755

  • FAX

    91-44-25231264/42677599

  • Chairman

  • Managing Director

  • Company Secretary

    A Mohanachandran

  • Auditor

    Brahmayya & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    V Floor,1 Club House Road
    Mumbai - Chennai - 600 002

Bafna Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bafna Pharma. 89.50 155.99 152.47 50.85 6.29
Abbott India 34,745.50 6,684.73 6,409.15 52.20 44.95
Astrazeneca Phar 8,953.35 1,330.33 1,295.53 193.38 33.26
P & G Health Ltd 5,920.55 1,166.89 1,151.26 39.13 39.76
Glaxosmi. Pharma 3,130.55 3,866.05 3,723.49 57.71 58.72
Cipla 1,473.35 20,029.57 19,044.85 23.08 21.40
Amrutanjan Healt 692.60 437.58 421.23 39.40 20.84
Fermenta Biotec. 379.25 442.21 430.53 16.51 17.61
Guj. Themis Bio. 372.55 174.19 169.82 83.16 44.82
Bliss GVS Pharma 156.90 703.42 667.20 23.99 9.16
Ambalal Sarabhai 34.60 19.33 4.04 32.04 2.10